Vitro, S.A.B. de C.V.
VITOF
$0.66
-$0.01-1.49%
OTC PK
| 09/30/2024 | 12/31/2023 | 09/30/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -10.95% | 105.26% | -87.00% | -87.00% | 7.08% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -10.95% | 105.26% | -87.00% | -87.00% | 7.08% |
| Cost of Revenue | 2.97% | 103.28% | -91.32% | -91.30% | 2.23% |
| Gross Profit | -25.18% | 114.66% | -73.57% | -73.60% | 24.07% |
| SG&A Expenses | -16.54% | 112.53% | -73.64% | -73.59% | 9.38% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -136.02% | -91.55% | 2,757.52% | 2,554.87% | 69.19% |
| Total Operating Expenses | -10.97% | 104.17% | -87.33% | -87.35% | 4.31% |
| Operating Income | -10.74% | 156.98% | -81.84% | -81.46% | 63.36% |
| Income Before Tax | -1,242.83% | 14.64% | -123.32% | -126.07% | 162.52% |
| Income Tax Expenses | -77.00% | 165.26% | -103.24% | -103.65% | -117.13% |
| Earnings from Continuing Operations | -1,818.60% | -11.30% | 88.71% | 87.42% | 323.59% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -56.86% | -- | 41.41% |
| Net Income | -340.13% | 1,462.43% | 190.82% | 188.60% | 320.32% |
| EBIT | -10.74% | 156.98% | -81.84% | -81.46% | 63.36% |
| EBITDA | -78.43% | 372.93% | -37.88% | -37.69% | 28.17% |
| EPS Basic | -333.33% | 1,088.82% | 200.00% | 199.33% | 300.00% |
| Normalized Basic EPS | -1,244.12% | -47.64% | -124.64% | -- | 148.73% |
| EPS Diluted | -333.33% | 1,088.82% | 200.00% | 199.33% | 300.00% |
| Normalized Diluted EPS | -1,244.12% | -47.64% | -124.64% | -- | 148.73% |
| Average Basic Shares Outstanding | 2.91% | -6.99% | -9.18% | -10.76% | 5.08% |
| Average Diluted Shares Outstanding | 2.91% | -6.99% | -9.18% | -10.76% | 5.08% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |